Study Finds Cannabis Compounds Hold Potential as Anticancer Agents

A scientific review on cancer and cannabis has concluded that various cannabinoids, including cannabidiol (CBD), cannabigerol (CBG) and delta-9 tetrahydrocannabinol (THC), hold promising potential as anticancer agents via different mechanisms.

Already, clinical trials have shown the effectiveness of cannabinoids in health improvement and the regression of tumors in palliative care.

The review was carried out by a team of nine scientists from schools in Turkey, Pakistan, South Korea, Romania, Portugal and Saudi Arabia. The researchers examined studies on the anticancer properties of cannabinoids, which included review articles, research papers and meta-analyzes involving in vivo, clinical and in vitro trials.

Their analysis covered different types of cancer, including glioma, breast cancer, melanoma, lung and leukemia. The researchers also investigated the use of cannabis in palliative care and patients undergoing chemotherapy, discovering that cannabinoids play a huge role in palliative care because it helped regulate pain, nausea and the patients’ appetites.

The review also showed that cannabinoids may work together with chemotherapy, with the study suggesting that the compounds could enhance the treatment’s cytotoxic effects via different mechanisms.

For example, delta-9 THC and CBD demonstrated that they could decrease cell proliferation and cause apoptosis when administered in conjunction with chemotherapeutic agents such as paclitaxel and cisplatin. These cannabinoids could also modulate pathways involved in apoptosis and regulation of cell cycles, which helped increase cancer cell susceptibility to death induced by chemotherapy.

In their report, the researchers highlighted the huge gaps in knowledge regarding marijuana’s mode of action and effects on the microenvironment of tumors, among others. They also acknowledged that hurdles to incorporating marijuana into cancer treatment remained, including determining optimal dosing and regulatory barriers. In addition, the researchers emphasized the need for further randomized trials to validate their findings and noted that by improving the understanding of the mechanisms of cannabinoids and their interactions with cancer cells, they could better harness their therapeutic potential.

Results of the review were published in the “Discover Oncology” journal.

Publication comes just after a special issue focusing on marijuana and cancer was published by the “National Cancer Institute.” The special issue centered on answering questions around the relationship patients had with marijuana, including reasons for use, behavioral patterns linked to the use of marijuana, associated cost and sourcing of the drug.

Earlier in the year, another study on the potential therapeutic value of marijuana compounds determined that some minor cannabinoids may possess anticancer effects on leukemia. These findings were reported in the “BioFactors” journal.

Such studies could provide inspiration for cannabis companies such as Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) to develop products targeting patients with particular forms of cancer. These treatments could supplement the conventional treatments currently being used to manage various cancers.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Archives

Select A Month
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • September 2016
  • August 2016
  • July 2016
  • Official NewsWire Relationships

    Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

    CannabisNewsWire Currently Accepts

    Bitcoin

    Bitcoin

    Bitcoin Cash

    Bitcoin Cash

    Doge Coin

    Dogecoin

    Ethereum

    Ethereum

    Litecoin

    Litecoin

    USD Coin

    USD Coin

    Contact us: 512.354.7000